"this means that for the first time, an injectionfree regimen will be recommended for all patients with rifampicin resistant tuberculosis in south africa.

melaotlhomo eno e tla baakanya tsela gore tlho komelo ya boitekanelo e fitlhe lesege bonolo ka nhi.
